Literature DB >> 16520129

Pericardial effusion: clinical and analytical parameters clues.

Gustavo Iglesias Cubero, José Rubin, Maria Martín, Juan Rondan, Eugenio Simarro.   

Abstract

Prospectively, clinical and biochemical data of 83 patients with a diagnosis of pericardial effusion were studied. The etiologies were as follows: Idiopathic: 42 cases (50%); Tuberculous: 18 cases (22%); Neoplastic: 14 cases (17%); Other: 9 cases (11%) with a miscellaneous etiology. Sedimentation rate resulted significantly higher in Tuberculous group (67-102), p<0.05. The highest values of adenosine deaminase in pericardial fluid were observed in Tuberculous group (110 U/l), p<0.001. Diagnosis of tuberculosis was established by culture of the bacillus in sputum in 8 cases and by pericardial biopsy in 11 patients. Analysis of the pericardial fluid leads to diagnosis in 25 cases (30%). The pericardial biopsy resulted as the most reliable method for the diagnosis of tuberculous pericarditis.

Entities:  

Mesh:

Year:  2006        PMID: 16520129     DOI: 10.1016/j.ijcard.2005.03.037

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  3 in total

1.  Etiology and Long-Term Outcome of Patients Undergoing Pericardiocentesis.

Authors:  Alexander Strobbe; Tom Adriaenssens; Johan Bennett; Christophe Dubois; Walter Desmet; Keir McCutcheon; Johan Van Cleemput; Peter R Sinnaeve
Journal:  J Am Heart Assoc       Date:  2017-12-23       Impact factor: 5.501

2.  Acute purulent pericarditis due co-infection with Staphylococcus aureus and Mycobacterium tuberculosis as first manifestation of HIV infection.

Authors:  Edgar Stroppa Lamas; Ricardo Jose Rogoni Bononi; Mario Vinicius Angelete Alvarez Bernardes; Junior Luiz Pasin; Hector Aurelio Davial Soriano; Henrique Tavares Martucci; Rafael Cezar Valentini
Journal:  Oxf Med Case Reports       Date:  2019-02-16

3.  Etiology of Pericardial Effusion and Outcomes Post Pericardiocentesis in the Western Region of Saudi Arabia: A Single-center Experience.

Authors:  Saad Albugami; Faisal Al-Husayni; Abdullah AlMalki; Mohammed Dumyati; Ysear Zakri; Jamilah AlRahimi
Journal:  Cureus       Date:  2020-01-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.